Common activities shared by CDK4 and CDK6 in cancer have been mostly identified and confirmed evaluating the roles of CDK4 and CDK6 specific inhibitors and, among them the principal is indubitably to promote cell proliferation by directly phosphorylating RB and indirectly through mTORC1 activation.318,319. This evidence concerns the gene RB1 and cancer.